[1] Goncalvesova E, Lesny P, Luknar M, et al. Changes of portal flow in heart failure patients with liver congestion[J]. Bratisl Lek Listy, 2010, 111(12): 635-639. [2] van Deursen VM, Damman K, Hillege HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients[J]. J Card Fail, 2010, 16(1): 84-90. [3] 陈灏珠. 心脏病学[M]. 5版. 北京: 人民卫生出版社, 2003: 407-411. [4] 李吉荣, 张拉春, 宋晓荣, 等. 缺血性肝炎的生化特点及白介素-6、C-反应蛋白水平变化[J]. 临床合理用药杂志, 2015, 8(2A):131-131,133. [5] Ambrosy AP, Vaduganathan M, Huffman MD, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial[J]. Eur J Heart Fail, 2012, 14(3): 302-311. [6] 夏邦俊, 袁先琢, 张祥宝, 等. 慢性心力衰竭患者肝功能损伤、肾功能不全发生率及其与心力衰竭严重程度的关系[J]. 实用医学杂志, 2009, 25(4): 580-581. [7] Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study[J]. Atherosclerosis, 2007, 191(2): 391-396. [8] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2): 98-122. [9] 邓新桃, 石桂良, 王如兴, 等. B型利钠肽水平对慢性心力衰竭患者预后的影响[J]. 中华心血管病杂志, 2012, 40(6): 462-466. |